Search results
Results from the WOW.Com Content Network
Claims like AG1’s are generally not approved or rejected by government regulators: Federal guidelines are mainly aimed at ensuring a product is safe, not that it is effective.
AG1, a recently discovered small molecule, has been shown to increase the activity of the G6PD enzyme in the three common variants of the deficiency. Due to the absence of medications to treat G6PD, AG1 is a promising precursor in developing a pharmacological treatment effective for multiple G6PD enzymopathies.
The researchers noted that the use of GLP-1 drugs in people with schizophrenia spectrum conditions helped with comorbid diabetes and obesity. The researchers found this promising in terms of ...
Patients who take glucagon-like peptide 1 (GLP-1) receptor agonists may be at increased risk of aspiration during anesthesia due to delayed gastric emptying, according to case reports. In 2023, the American Society of Anesthesiologists suggested holding the GLP-1 agonists on the day of the procedure/surgery or a week earlier.
Cole was an AG1 customer before she was hired by the company and says it was the “quality of the product,” and the impact it had on her “energy, gut health, and immune system,” that piqued ...
Katrina "Kat" Cole (born March 18, 1978) is an American businesswoman. She is the CEO of AG1, formerly known as Athletic Greens. She was previously the chief operating officer and president of North America for Focus Brands and the president of Focus Brands' subsidiary Cinnabon, an American chain of retail bakeries specializing in cinnamon buns. [1]
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for weight loss, and supplements for heart health.
Airborne is an American brand of dietary supplement containing herbal extracts, amino acids, antioxidants, electrolytes, vitamins, and other ingredients originally marketed as preventing the common cold and improving immune function.